We address the problem of unsupervised domain adaptation when the source domain differs from the target domain because of a shift in the distribution of a latent subgroup. When this subgroup confounds all observed data, neither covariate shift nor label shift assumptions apply. We show that the optimal target predictor can be non-parametrically identified with the help of concept and proxy variables available only in the source domain, and unlabeled data from the target. The identification results are constructive, immediately suggesting an algorithm for estimating the optimal predictor in the target. For continuous observations, when this algorithm becomes impractical, we propose a latent variable model specific to the data generation process at hand. We show how the approach degrades as the size of the shift changes, and verify that it outperforms both covariate and label shift adjustment.
Machine learning (ML) holds great promise for improving healthcare, but it is critical to ensure that its use will not propagate or amplify health disparities. An important step is to characterize the (un)fairness of ML models - their tendency to perform differently across subgroups of the population - and to understand its underlying mechanisms. One potential driver of algorithmic unfairness, shortcut learning, arises when ML models base predictions on improper correlations in the training data. However, diagnosing this phenomenon is difficult, especially when sensitive attributes are causally linked with disease. Using multi-task learning, we propose the first method to assess and mitigate shortcut learning as a part of the fairness assessment of clinical ML systems, and demonstrate its application to clinical tasks in radiology and dermatology. Finally, our approach reveals instances when shortcutting is not responsible for unfairness, highlighting the need for a holistic approach to fairness mitigation in medical AI.
We propose a novel reduction-to-binary (R2B) approach that enforces demographic parity for multiclass classification with non-binary sensitive attributes via a reduction to a sequence of binary debiasing tasks. We prove that R2B satisfies optimality and bias guarantees and demonstrate empirically that it can lead to an improvement over two baselines: (1) treating multiclass problems as multi-label by debiasing labels independently and (2) transforming the features instead of the labels. Surprisingly, we also demonstrate that independent label debiasing yields competitive results in most (but not all) settings. We validate these conclusions on synthetic and real-world datasets from social science, computer vision, and healthcare.
Literature on machine learning for multiple sclerosis has primarily focused on the use of neuroimaging data such as magnetic resonance imaging and clinical laboratory tests for disease identification. However, studies have shown that these modalities are not consistent with disease activity such as symptoms or disease progression. Furthermore, the cost of collecting data from these modalities is high, leading to scarce evaluations. In this work, we used multi-dimensional, affordable, physical and smartphone-based performance outcome measures (POM) in conjunction with demographic data to predict multiple sclerosis disease progression. We performed a rigorous benchmarking exercise on two datasets and present results across 13 clinically actionable prediction endpoints and 6 machine learning models. To the best of our knowledge, our results are the first to show that it is possible to predict disease progression using POMs and demographic data in the context of both clinical trials and smartphone-base studies by using two datasets. Moreover, we investigate our models to understand the impact of different POMs and demographics on model performance through feature ablation studies. We also show that model performance is similar across different demographic subgroups (based on age and sex). To enable this work, we developed an end-to-end reusable pre-processing and machine learning framework which allows quicker experimentation over disparate MS datasets.
Machine learning (ML) approaches have demonstrated promising results in a wide range of healthcare applications. Data plays a crucial role in developing ML-based healthcare systems that directly affect people's lives. Many of the ethical issues surrounding the use of ML in healthcare stem from structural inequalities underlying the way we collect, use, and handle data. Developing guidelines to improve documentation practices regarding the creation, use, and maintenance of ML healthcare datasets is therefore of critical importance. In this work, we introduce Healthsheet, a contextualized adaptation of the original datasheet questionnaire ~\cite{gebru2018datasheets} for health-specific applications. Through a series of semi-structured interviews, we adapt the datasheets for healthcare data documentation. As part of the Healthsheet development process and to understand the obstacles researchers face in creating datasheets, we worked with three publicly-available healthcare datasets as our case studies, each with different types of structured data: Electronic health Records (EHR), clinical trial study data, and smartphone-based performance outcome measures. Our findings from the interviewee study and case studies show 1) that datasheets should be contextualized for healthcare, 2) that despite incentives to adopt accountability practices such as datasheets, there is a lack of consistency in the broader use of these practices 3) how the ML for health community views datasheets and particularly \textit{Healthsheets} as diagnostic tool to surface the limitations and strength of datasets and 4) the relative importance of different fields in the datasheet to healthcare concerns.
Fairness and robustness are often considered as orthogonal dimensions when evaluating machine learning models. However, recent work has revealed interactions between fairness and robustness, showing that fairness properties are not necessarily maintained under distribution shift. In healthcare settings, this can result in e.g. a model that performs fairly according to a selected metric in "hospital A" showing unfairness when deployed in "hospital B". While a nascent field has emerged to develop provable fair and robust models, it typically relies on strong assumptions about the shift, limiting its impact for real-world applications. In this work, we explore the settings in which recently proposed mitigation strategies are applicable by referring to a causal framing. Using examples of predictive models in dermatology and electronic health records, we show that real-world applications are complex and often invalidate the assumptions of such methods. Our work hence highlights technical, practical, and engineering gaps that prevent the development of robustly fair machine learning models for real-world applications. Finally, we discuss potential remedies at each step of the machine learning pipeline.
Interpretability techniques aim to provide the rationale behind a model's decision, typically by explaining either an individual prediction (local explanation, e.g. `why is this patient diagnosed with this condition') or a class of predictions (global explanation, e.g. `why are patients diagnosed with this condition in general'). While there are many methods focused on either one, few frameworks can provide both local and global explanations in a consistent manner. In this work, we combine two powerful existing techniques, one local (Integrated Gradients, IG) and one global (Testing with Concept Activation Vectors), to provide local, and global concept-based explanations. We first validate our idea using two synthetic datasets with a known ground truth, and further demonstrate with a benchmark natural image dataset. We test our method with various concepts, target classes, model architectures and IG baselines. We show that our method improves global explanations over TCAV when compared to ground truth, and provides useful insights. We hope our work provides a step towards building bridges between many existing local and global methods to get the best of both worlds.
Recurrent Neural Networks (RNNs) are often used for sequential modeling of adverse outcomes in electronic health records (EHRs) due to their ability to encode past clinical states. These deep, recurrent architectures have displayed increased performance compared to other modeling approaches in a number of tasks, fueling the interest in deploying deep models in clinical settings. One of the key elements in ensuring safe model deployment and building user trust is model explainability. Testing with Concept Activation Vectors (TCAV) has recently been introduced as a way of providing human-understandable explanations by comparing high-level concepts to the network's gradients. While the technique has shown promising results in real-world imaging applications, it has not been applied to structured temporal inputs. To enable an application of TCAV to sequential predictions in the EHR, we propose an extension of the method to time series data. We evaluate the proposed approach on an open EHR benchmark from the intensive care unit, as well as synthetic data where we are able to better isolate individual effects.
ML models often exhibit unexpectedly poor behavior when they are deployed in real-world domains. We identify underspecification as a key reason for these failures. An ML pipeline is underspecified when it can return many predictors with equivalently strong held-out performance in the training domain. Underspecification is common in modern ML pipelines, such as those based on deep learning. Predictors returned by underspecified pipelines are often treated as equivalent based on their training domain performance, but we show here that such predictors can behave very differently in deployment domains. This ambiguity can lead to instability and poor model behavior in practice, and is a distinct failure mode from previously identified issues arising from structural mismatch between training and deployment domains. We show that this problem appears in a wide variety of practical ML pipelines, using examples from computer vision, medical imaging, natural language processing, clinical risk prediction based on electronic health records, and medical genomics. Our results show the need to explicitly account for underspecification in modeling pipelines that are intended for real-world deployment in any domain.
The recent use of `Big Code' with state-of-the-art deep learning methods offers promising avenues to ease program source code writing and correction. As a first step towards automatic code repair, we implemented a graph neural network model that predicts token types for Javascript programs. The predictions achieve an accuracy above $90\%$, which improves on previous similar work.